Press Releases

Press Releases

Filters
Viatris Inc. Releases Inaugural Sustainability Report, Reinforcing its Commitment to Better Health and Better Communities Worldwide
Viatris Inc. to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
Viatris Inc. to Participate in BofA Securities 2021 Health Care Conference
Viatris Inc. to Release First Quarter 2021 Financial Results on May 10, 2021
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
Viatris Inc. to Participate in Barclays Global Healthcare Conference
Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platform, and Focus on CSR and Financial Commitments
Viatris Inc. Announces 2021 Financial Guidance and Reaffirms Strategic and Financial Commitments
Viatris Inc. to Hold Conference Call on Monday, Feb. 22, 2021, to Discuss 2021 Financial Guidance
Mylan Wins Summary Judgment in EpiPen® Litigation Brought by Sanofi
Displaying 1 - 10 of 16